NASDAQ:SPNS - Sapiens International Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $34.71
  • Forecasted Upside: 10.06 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$31.54
▲ +0.52 (1.68%)
1 month | 3 months | 12 months
Get New Sapiens International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SPNS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SPNS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$34.71
▲ +10.06% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Sapiens International in the last 3 months. The average price target is $34.71, with a high forecast of $40.00 and a low forecast of $25.00. The average price target represents a 10.06% upside from the last price of $31.54.
Buy
The current consensus among 7 investment analysts is to buy stock in Sapiens International. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/30/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/21/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/20/2021Jefferies Financial GroupInitiated CoverageBuy$39.00N/A
i
1/13/2021The Goldman Sachs GroupInitiated CoverageNeutral$35.00Low
i
12/22/2020Smith Barney CitigroupInitiated CoverageBuy$33.00Low
i
12/22/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated CoverageBuy$33.00High
i
10/26/2020JPMorgan Chase & Co.Initiated CoverageOverweight$40.00Low
i
8/5/2020BarclaysReiterated RatingHoldMedium
i
8/4/2020Needham & Company LLCBoost Price TargetBuy$28.00 ➝ $38.00High
i
Rating by Mayank Tandon at Needham & Company LLC
5/14/2020Needham & Company LLCReiterated RatingBuy$28.00Low
i
Rating by Mayank Tandon at Needham & Company LLC
2/25/2020BarclaysReiterated RatingHold$25.00High
i
2/24/2020Needham & Company LLCBoost Price TargetBuy$26.00 ➝ $28.00High
i
Rating by Mayank Tandon at Needham & Company LLC
11/21/2019Needham & Company LLCReiterated RatingBuy$26.00Low
i
Rating by Mayank Tandon at Needham & Company LLC
11/4/2019Needham & Company LLCReiterated RatingBuy$26.00High
i
8/7/2019BarclaysReiterated RatingHoldMedium
i
8/5/2019Roth CapitalBoost Price Target$5.00 ➝ $8.75High
i
2/27/2019BarclaysReiterated RatingHold$14.50High
i
11/9/2018CowenReiterated RatingBuyMedium
i
11/8/2018BarclaysReiterated RatingHoldHigh
i
8/8/2018Needham & Company LLCBoost Price TargetBuy$13.00 ➝ $14.00Medium
i
8/7/2018William BlairReiterated RatingMarket PerformLow
i
Rating by B. Suri at William Blair
5/8/2018William BlairDowngradeOutperform ➝ Market PerformLow
i
Rating by B. Suri at William Blair
3/8/2018William BlairReiterated RatingOutperformHigh
i
Rating by B. Suri at William Blair
2/16/2018BarclaysDowngradeOverweight ➝ Equal WeightHigh
i
10/12/2017CowenReiterated RatingBuy$14.00N/A
i
9/6/2017CowenInitiated CoverageOutperform$14.00Medium
i
5/15/2017William BlairReiterated RatingOutperformMedium
i
Rating by B. Suri at William Blair
4/28/2017Needham & Company LLCLower Price TargetBuy ➝ Buy$17.00 ➝ $16.00High
i
3/3/2017BarclaysReiterated RatingBuyN/A
i
3/1/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$16.00 ➝ $17.00N/A
i
2/15/2017Needham & Company LLCReiterated RatingBuy$16.00N/A
i
11/8/2016Needham & Company LLCBoost Price TargetBuy$15.00 ➝ $16.00N/A
i
10/19/2016Credit Suisse GroupInitiated CoverageOutperformN/A
i
8/5/2016BarclaysBoost Price TargetOverweight$14.00 ➝ $15.00N/A
i
7/10/2016Roth CapitalReiterated RatingSellN/A
i
Rating by Richard Baldry at Roth Capital
5/11/2016Roth CapitalReiterated RatingNeutral ➝ Sell$11.00N/A
i
Rating by R. Baldry at Roth Capital
2/17/2016Needham & Company LLCReiterated RatingBuy$14.00 ➝ $15.00N/A
i
Rating by Mayank Tandon at Needham & Company LLC
(Data available from 1/20/2016 forward)
Sapiens International logo
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers Sapiens CoreSuite and Sapiens IDITSuite for personal, commercial, and specialty lines, as well as reinsurance and workers' compensation; and Sapiens CoreSuite, Sapiens UnderwritingPro, Sapiens ApplicationPro, Sapiens IllustrationPro, and Sapiens ConsolidationMaster for life, pension, and annuities. It also provides Sapiens DigitalSuite for insurance customers, agents, brokers, risk managers, customer groups and third-party service providers; Sapiens AgentConnect and Sapiens CustomerConnect portals; Sapiens Intelligence, an analytics platform; Sapiens IntelligencePro, a comprehensive BI solution with pre-configured reports, dashboards, and scorecards; and Sapiens Advanced Analytics, which uses AI and Machine Learning to generate actionable insights based on different models across the insurance value chain. In addition, the company offers Sapiens ReinsuranceMaster, Sapiens ReinsurancePro, and Sapiens Reinsurance GO reinsurance solutions; and Sapiens Platform, Sapiens CoreSuite, Sapiens PolicyPro, and Sapiens ClaimsPro, as well as Sapiens PolicyGo, Sapiens ClaimsGo, and Sapiens Connect for workers' compensation. Further, it provides financial and compliance solutions, which comprise Sapiens FinancialPro, Sapiens Financial GO, Sapiens StatementPro, Sapiens CheckPro, and Sapiens Reporting Tools; and Sapiens Decision, an enterprise-scale platform that enables institutions to centrally author, store, and manage various organizational business logics. Additionally, the company offers tailor-made solutions based on its Sapiens eMerge platform; and program delivery, business, and managed services. It markets and sells its products and services through direct and partner sales. The company was founded in 1982 and is headquartered in Holon, Israel.
Read More

Today's Range

Now: $31.54
$30.97
$31.77

50 Day Range

MA: $29.65
$27.45
$31.58

52 Week Range

Now: $31.54
$13.55
$35.23

Volume

144,687 shs

Average Volume

155,181 shs

Market Capitalization

$1.60 billion

P/E Ratio

50.87

Dividend Yield

0.45%

Beta

1.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Sapiens International?

The following Wall Street analysts have issued research reports on Sapiens International in the last twelve months: Barclays PLC, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, JPMorgan Chase & Co., Needham & Company LLC, Smith Barney Citigroup, The Goldman Sachs Group, Inc., and Zacks Investment Research.

What is the current price target for Sapiens International?

6 Wall Street analysts have set twelve-month price targets for Sapiens International in the last year. Their average twelve-month price target is $34.00, suggesting a possible upside of 7.8%. JPMorgan Chase & Co. has the highest price target set, predicting SPNS will reach $40.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $25.00 for Sapiens International in the next year.

What is the current consensus analyst rating for Sapiens International?

Sapiens International currently has 2 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SPNS will outperform the market and that investors should add to their positions of Sapiens International.

What other companies compete with Sapiens International?

How do I contact Sapiens International's investor relations team?

Sapiens International's physical mailing address is Azrieli Center 26 Harukmim St., Holon L3, 5885800. The technology company's listed phone number is 972-3790-2000 and its investor relations email address is yaffa.cohen-ifrah@sapiens.com. The official website for Sapiens International is www.sapiens.com.